Enzolytics Inc (ENZC)

[southswell7]

TODAYS MUST READ DD WITH OTCShotCallers Great DD ADDED

I said in September, October is our Month. Recognition, but even more with all the talk in the Media and Pharmas in regards to Monoclonal Anitbodies.

If I were a betting man, oh which I am, I would say we get News This OR Next Week. In all my DD, I say once Filings/Merger Hit, You Best Hold Every Share Tight!! Look at alllll the Companies looking for a Company like BioClonetics who have all the years studying about DONE. HIV, Covid, Sars, Ebola, on and on. Disease is our new Norm worldwide. They will want to Partner, to Produce, to even Buy us Out in Time!! Guaranteed! After Merger, OMG WE COULD SEE MONSTER NASDAQ NYSE NAMES WITH US!!!

DD all the Big Pharmas, and the success and or failures with Covid especially. All on the Internet. We have ties to Johnson and Johnson from 2 years ago, and posted. Think they are licking their chops now?
Quote:
In a conversation this week with Johnson & Johnson, a company focused on HIV therapy, our technology was well received and recognized as being significant and the data persuasive. However, Johnson and Johnson indicated that it would need to see results in animal trials before it would be in a position to buy-in to the technology.

https://www.linkedin.com/pulse/our-anti-hiv-monoclonal-antibody-progress-charles-s-cotropia?articleId=6454774694473187328#comments-6454774694473187328&trk=public_profile_article_view

Think Gilead Sciences, who Charles follows intently. Click his LinkedIn!! https://www.linkedin.com/in/charles-s-cotropia-3059a25/

Some of the EASIEST DD TO DO is see WHO/What Companies the Top Interest is in. Boom Gilead!! I posted a article with the perfect example the other day in regards to them. Here it is, Some say it is too long to read, lmfao!! DD!! Think outside the box. Y R U trading the OTC then?? U know who you are!
This article is MASSIVE and not 1 response. Here is 1 Company that we know and they know BioClonetics. One never knows, but this is just the start!

https://pharmalive.com/gilead-2020-hiv-and-covid/ The Opportunity is ENOURMOUS

Also, Charles follows a Company named Tibotec. Hmmmm, DD them! Oh, they Tibotec was a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceutica

https://www.janssen.com/ Johnson and Johnson Wow!! Easy DD! JNJ AGAIN!

How about Geovax Labs who Charles follows: https://www.geovax.com/ or BioClonetics newest Following of ViiV Healthcare
@ViiVUS https://viivhealthcare.com/en-us/ But look at who they are by! ViiV Healthcare is a pharmaceutical company specializing in the development of therapies for HIV infection that was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company.

THEN.... https://www.linkedin.com/company/viiv-healthcare/ I like those names listed! GlaxoSmithKline!! GlaxoSmithKline Loves Buying Pharma/Biotech Companies! Could in the future!!

How about who Joseph's main Company he has Interest in....Eli Lilly https://www.linkedin.com/in/joseph-cotropia-md-bb5a879/

Lilly’s Covid-19 Antibody Helps Patients Rid Their Systems Of Virus Sooner
A drug being developed by Eli Lilly helped sick patients rid their systems of the virus that causes Covid-19 sooner and may have prevented them from landing in the hospital, according to newly released data. The drug is what is known as a monoclonal antibody, which experts view as being among the most likely technologies to help treat Covid-19. It’s a manufactured version of the antibodies that the body uses as part of its response to a virus. (Herper and Garde, 9/16)

Sooo many we can and will be in bed with. Dig people!! GlaxoSmithKline,Lilly,JNJ,Merck,Gilead,Phizer, on and on!!

Look at all the experience Guarav Chandra has, our COO!! His Companies, DD them that his his interest! DAMN! TIES/CONNECTIONS! https://www.linkedin.com/in/gaurav-chandra-md-mba-a8964b74/

If You give your shares away this close to the shit hitting the fan, you will NOT get those shares back as OUTSIDE Money will take them from you and HOLD LONG. Count on it.

One video I watched today. THINK...Serum Institute

"It's going to be at least 2024." @AdarPoonawalla CEO @SerumInstIndia, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against #covid19. They’re raising $850M to help fund it. Part 1 👇🏻 pic.twitter.com/H6bWglXs18

— Julia Chatterley (@jchatterleyCNN) September 22, 2020

OTCShotCaller Huge DD:

Biomedical Research Patent History

Dr. Fauci
No. of Patents: 1,848

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&Query=fauci


Dr. Cotropia
No. of Patents: 242

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&Query=Cotropia


Based on this information proving Dr. Cotropia's world class Bio-Medical Science Research background that fundamentally is "on par" with Dr. Fauci, combined with Cotropia's superior Clone-3 Antibody Patent that clearly represents "Disruption Technology" for potential AIDS/HIV curative treatment as a Monotherapy approach for most HIV strains, and possibly Covid-19, the above is all I needed to see to make the decision to invest in Enzolytics-BioClonetics. For me it was a "no brainer", it didn't take a lot of thought because I know who these guys are!

The clinical implications of this is extraordinarily profound and the Patent Cotropia holds on Clone-3, in and of itself, and all by itself, independent of bringing it to market, is worth $Billions$$ far beyond any AIDS/HIV drug therapies that have been commercialized for clinical application thus far.

There's nothing like this that presently exists in the marketplace.

Let me be very clear about something, both Fauci and Cotropia are world class leaders in infectious disease investigational research and treatment.

Therefore, it was an easy decision for me to invest in Enzolytics-Bioclonetics based on my own Bio-Medical Science research background in University based Academic Medicine & BigPharma Clinical Research patient trials.

Much is converging here...right place...right time...right players...Disruptive Technology....the only curative hope for HIV in sight standing before humanity...readily available massive funding from many sources...the time to make it happen is NOW!!!

Enzolytics-BioClonetics....a global BigPharma Superstar in the making unlike anything the world has ever seen!

Time for liftoff!

Be well and prosper .....

DO NOT FORGET OUR VERY VALUABLE PATENTS from HARRY and ENZOLYTICS